IOVA — Iovance Biotherapeutics Inc. stock price and chart

Share this page

IOVA

$13.62-7.47%

as of close, Oct 16, 2026

☾ AH $13.62 -7.47%

Iovance Biotherapeutics Inc.Stock · HealthcareRussell 2000 0.05%Nasdaq Composite 0.005%US Stock Market 0.002%Russell 3000 0.001%

PeersMRNALLYMDTUNHJNJTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeEEEE

20162019202120242026

5.010.015.020.025.030.035.040.045.050.00100.0M200.0M$13.62

2026-10-16

Price$13.62

MA20$6.88

MA50$4.41

Vol72.2M

What would $1,000 invested in IOVA be worth today? →

IOVA returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $13.62
YTD price return: +398.90%
YTD total return: +398.90%
Next earnings: Nov 5, 2026
Market cap: 6.2B2016-12 431.5M2026-10 6.2B+1331.3% over the window
Enterprise value: 5.9B
Shares outstanding: 453M2016-06 58.4M2026-06 453M+675.2% over the window
52W low: $1.76
52W high: $15.30
From 52W high: -10.98%
From 52W low: +673.86%
52W range: 88%

Volume

Rel volume: 0.73×
30D volume: 16.7M
30D $ vol: 202.8M

Fundamentals

Sales (ttm): 325M2016-06 02026-06 325M
Sales/share: $0.722016-06 $0.002026-06 $0.72
EPS (ttm): -$0.642019-12 -$1.592026-06 -$0.64-59.6% over the window
FCF (ttm): -296.4M2016-06 -19M2026-06 -296.4M+1459.8% over the window
FCF/share: -$0.652016-06 -$0.332026-06 -$0.65+101.2% over the window
Book value/share: $1.622016-06 $3.232026-06 $1.62-49.7% over the window
Net margin: -89.09%2023-12 -37345.4%2026-06 -89.1%-99.8% over the window
ROE: -39.33%2016-06 -18.2%2026-06 -39.3%+115.8% over the window
ROA: -31.62%2016-06 -17.8%2026-06 -31.6%+77.7% over the window
Current ratio: 4.352016-06 41.762026-06 4.35-89.6% over the window

Growth (CAGR, ttm) · 10Y

Sales: +34.58%2025-06-30 → 2026-06-30241.5M → 325M (+34.5% total)+845.95%2023-12-31 → 2026-06-301.2M → 325M (+27231.3% total)n/an/a
Shares: +25.20%2025-06-30 → 2026-06-30361.9M → 453M (+25.2% total)+22.27%2023-06-30 → 2026-06-30247.8M → 453M (+82.8% total)+23.96%2021-06-30 → 2026-06-30154.8M → 453M (+192.6% total)+22.73%2016-06-30 → 2026-06-3058.4M → 453M (+675.2% total)

Per-share growth (CAGR, ttm) · 10Y

Sales/share: +7.49%2025-06-30 → 2026-06-30$0.67 → $0.72 (+7.5% total)+679.41%2023-12-31 → 2026-06-30$0.00 → $0.72 (+16752.8% total)n/an/a
Book value/share: -15.83%2025-06-30 → 2026-06-30$1.93 → $1.62 (-15.8% total)-11.38%2023-06-30 → 2026-06-30$2.34 → $1.62 (-30.4% total)-19.51%2021-06-30 → 2026-06-30$4.81 → $1.62 (-66.2% total)-6.65%2016-06-30 → 2026-06-30$3.23 → $1.62 (-49.7% total)
Price: +508.79%2025-10-16 → 2026-10-16$2.24 → $13.62 (+508.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+56.24%2023-10-16 → 2026-10-16$3.57 → $13.62 (+281.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-12.53%2021-10-15 → 2026-10-16$26.61 → $13.62 (-48.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+7.93%2016-10-14 → 2026-10-16$6.35 → $13.62 (+114.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +508.79%2025-10-16 → 2026-10-16$2.24 → $13.62 (+508.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+56.24%2023-10-16 → 2026-10-16$3.57 → $13.62 (+281.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-12.53%2021-10-15 → 2026-10-16$26.61 → $13.62 (-48.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+7.93%2016-10-14 → 2026-10-16$6.35 → $13.62 (+114.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: -21.2×2016-12 -4.542026-10 -21.33+369.8% over the window
Fwd P/E: -67.9×
P/S (ttm)Market cap ÷ TTM revenue.: 19.0×2024-03 3481.352026-10 19.01-99.5% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 8.4×2016-12 2.412026-10 8.39+248.3% over the window
EV/Sales (ttm): 18.2×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: -4.80%2016-09 -6.5%2026-06 -15.7%+142.2% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 453.0M ÷ 361.9M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -25.20%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-25.20%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($622.4M). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -25.20%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($-292.4M) ÷ today's market cap ($6.2B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: -4.74%2016-09 -22.2%2026-06 -15.5%-30.0% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $-292.4M + TTM dividends $0) ÷ today's market cap ($6.2B). Same caveat as the cash buyback yield.: -4.74%2016-09 -22.2%2026-06 -15.5%-30.0% over the window

Vs own 10Y history

P/B: 90th

Bar = where today’s multiple sits in IOVA’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-16#

-7.47%

-6.84%

+37.99%

+192.27%

YTD

+398.90%

+508.04%

-48.82%

Financial statements

Open full IOVA financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+10.48%	+0.43%
JNJ	Johnson & Johnson	-4.38%	+0.90%
ABBV	AbbVie Inc.	+8.73%	+0.71%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+6.97%	-1.29%
MRK	Merck & Co. Inc.	+0.72%	+0.52%
NVS	Novartis AG	+8.59%	+0.16%
TMO	Thermo Fisher Scientific Inc.	+6.41%	-0.93%
AMGN	Amgen Inc.	+14.92%	-0.35%

IOVA — Iovance Biotherapeutics Inc. price, chart and key statistics